Colucid Pharma Cmn (CLCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | |
| Operating Expenses | 30,882 | 2,310 | 1,563 |
| Operating Income | -30,882 | -2,310 | -1,563 |
| Interest Expense | 0 | 397 | 631 |
| Other Income | 142 | 1 | 1 |
| Pre-tax Income | -30,740 | -2,706 | -2,194 |
| Income Tax | N/A | 248 | 0 |
| Net Income Continuous | -30,740 | -2,953 | -2,194 |
| Net Income | $-30,740 | $-2,953 | $-2,194 |
| EPS Basic Total Ops | -3.82 | -20.96 | -21.61 |
| EPS Basic Continuous Ops | -3.05 | -20.95 | -21.51 |
| EPS Diluted Total Ops | -3.82 | -20.96 | -21.61 |
| EPS Diluted Continuous Ops | -3.05 | -20.95 | -21.51 |
| EPS Diluted Before Non-Recurring Items | -3.82 | N/A | N/A |
| EBITDA(a) | $-30,649 | $-2,308 | $-1,563 |